Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
Robert L. Wilensky(Hospital of the University of Pennsylvania), Yi Shi(Thomas Jefferson University), Emile R. Mohler(Hospital of the University of Pennsylvania), Damir Hamamdzic(Hospital of the University of Pennsylvania), Mark Burgert(GlaxoSmithKline (India)), Jun Li(CSL (United States)), Anthony D. Postle(Southampton General Hospital), Robert S. Fenning(Hospital of the University of Pennsylvania), James G. Bollinger(University of Washington), Bryan E. Hoffman(GlaxoSmithKline (India)), Daniel J. Pelchovitz(Hospital of the University of Pennsylvania), Jisheng Yang(Hospital of the University of Pennsylvania), Rosanna C. Mirabile(GlaxoSmithKline (India)), Christine L. Webb(GlaxoSmithKline (India)), LeFeng Zhang(Thomas Jefferson University), Ping Zhang(Thomas Jefferson University), Michael H. Gelb(University of Washington), Max Walker(GlaxoSmithKline (India)), Andrew Zalewski(GlaxoSmithKline (India)), Colin H. Macphee(GlaxoSmithKline (India))
Cited by 388Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis